The present paper demonstrates that among all of the proteins tested in our investigations, serum M-CSF, CXCL-8, IL-6 and TIMP-1 are better biomarkers than the currently used, well-established classical tumor marker—CEA—in the diagnosis of CRC. This evidence concerns the gene CXCL8 and neoplasm.